Back
ESC2025 Premium Access

Incremental prognostic value of right ventricular free wall longitudinal strain in a staging classification based on cardiac damage in patients with severe aortic stenosis who underwent TAVI

Session: Imaging in valvular heart disease
Topic: Valvular Heart Disease
Speaker: Doctor K. Sato (Tsukuba, JP)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Kimi Sato

University of Tsukuba, Tsukuba (Japan)
0 follower

7 more presentations in this session

Prognostic impact of normalizing 3D mitral RegVol to LAVmax in HFrEF patients with ventricular secondary MR

Speaker: Assistant Professor D. Hadareanu (Craiova, RO)

Access
Abstract
Slides
Video
Like
Thumbnail

Prognostic impact of left atrial and ventricular strain coupling after TAVR: a novel risk assessment approach

Speaker: Doctor R. Wimolwattanaphan (Bangkok, TH)

Access
Abstract
Slides
Video
Like
Thumbnail

Impact of symptoms and left ventricular systolic function in patients with moderate mixed aortic valve disease

Speaker: Mrs P. Lopez Santi (Leiden, NL)

Access
Abstract
Slides
Video
Like
Thumbnail

Improvement of tricuspid regurgitation in patients treated with transcatheter aortic valve replacement: prognostic impact and factors associated with its regression after the intervention.

Speaker: Doctor L. Milla Mendoza (Madrid, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

Transjugular intracardiac echocardiography-guided transcatheter aortic valve replacement using intra-annular self-expandable valves to reduce permanent pacemaker implantation

Speaker: Doctor T. Murakami (Kanagawa, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Imaging in valvular heart disease

Speakers: Doctor K. Sato, Assistant Professor D. Hadareanu, Doctor R. Wimolwattanaphan, Mrs P. Lopez Santi, Doctor L. Milla Mendoza...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources